WST West Pharmaceutical Services Inc stock chart & analysis
Conviction 38HealthcareScan · Fri, Nov 6, 2026West Pharmaceutical Services Inc (WST) closed at $399.81 (+1.87%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 58, RS Rating 93, -8.8% from its 52-week high, +45.3% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
WST technical analysis
Trend
WST is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 7.2% above the 50-day ($372.90) and 26.1% above the 200-day ($316.99). ADX(14) at 46 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 58, in the bullish half of its range. MACD crossed below its signal line one session ago. Its RS Rating of 93 puts its weighted 12-month performance ahead of about 93% of the US market, and its RS line is at a new high.
Volume and volatility
Volume on the latest session ran 0.9× its 20-day average. It trades about $306.2M a day on average. ATR(14) is $11.26, 2.8% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (-0.13) shows distribution.
Key levels
The chart pattern's support is $360.71 and its resistance $417.71. The 52-week range is $223.83 to $438.27; price is 8.8% below the high and 78.6% above the low. The VWAP anchored at the 52-week high is $411.39, above price.
Performance
WST returned -3.1% (1 week), +10.1% (1 month), +13.5% (3 months), +22.7% (6 months), +41.0% (1 year), +45.3% (year to date).
About West Pharmaceutical Services Inc
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Surgical & Medical Instruments & Apparatus · Listed 1973 · 10,800 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upAug 17 – Oct 145 scans
- Breaking out nowOct 151 scan
- Setting upOct 16 – Oct 192 scans
Recent news
- WEST PHARMACEUTICAL SERVICES INC: Ownership stake amendedSEC EDGAR · Thu, Nov 5, 2026
- West to Participate in Upcoming Investor ConferencePR Newswire · Wed, Nov 4, 2026
Congress activity
Disclosed STOCK Act trades in WST · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Lisa McClain house · R · MI · traded 2025-07-22 | Sell | $1K–$15K | 2025-07-22 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
 Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Buy | $1K–$15K | 2025-02-25 | 2025-03-27 | |
 Jared Moskowitz house · D · FL · traded 2025-02-13 | Sell | $1K–$15K | 2025-02-13 | 2025-03-06 | |
Jared Moskowitz house · FL · traded 2023-12-28 | Buy | $1K–$15K | 2023-12-28 | 2024-08-12 |
Insider activity
SEC Form 4 transactions in WST · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Favorite Annette F Sr. VP & Chief HR Officer · Stock Option (Right to Buy) · 2026-09-15 | Exercise | 2.52K | — | 2026-09-15 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Common Stock · 2026-09-15 | Exercise | 2.52K | $226K | 2026-09-15 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Common Stock · 2026-09-15 | Sell | 2.52K | $921K | 2026-09-15 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Common Stock · 2026-09-14 | Sell | 2.5K | $888K | 2026-09-14 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Stock Option (Right to Buy) · 2026-09-14 | Exercise | 2.5K | — | 2026-09-14 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Common Stock · 2026-09-14 | Exercise | 2.5K | $224K | 2026-09-14 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Common Stock · 2026-09-11 | Sell | 2.5K | $863K | 2026-09-11 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Common Stock · 2026-09-11 | Exercise | 2.5K | $224K | 2026-09-11 | 2026-09-15 |
Favorite Annette F Sr. VP & Chief HR Officer · Stock Option (Right to Buy) · 2026-09-11 | Exercise | 2.5K | — | 2026-09-11 | 2026-09-15 |
McMahon Robert W. SVP & Chief Financial Officer · Common Stock · 2026-08-11 | Exercise | 794.469 | — | 2026-08-11 | 2026-08-12 |
SEC filings
EDGAR filings in WST · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.